chr18-2706361-C-T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_015295.3(SMCHD1):​c.1957-3C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000711 in 1,540,260 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00052 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00073 ( 4 hom. )

Consequence

SMCHD1
NM_015295.3 splice_region, intron

Scores

2
Splicing: ADA: 0.0002092
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 0.637

Publications

0 publications found
Variant links:
Genes affected
SMCHD1 (HGNC:29090): (structural maintenance of chromosomes flexible hinge domain containing 1) This gene encodes a protein which contains a hinge region domain found in members of the SMC (structural maintenance of chromosomes) protein family. [provided by RefSeq, Dec 2011]
SMCHD1 Gene-Disease associations (from GenCC):
  • arhinia, choanal atresia, and microphthalmia
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, G2P, Ambry Genetics, ClinGen, Illumina
  • facioscapulohumeral muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 18-2706361-C-T is Benign according to our data. Variant chr18-2706361-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 260635. Variant chr18-2706361-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 260635. Variant chr18-2706361-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 260635. Variant chr18-2706361-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 260635. Variant chr18-2706361-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 260635.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000519 (79/152174) while in subpopulation SAS AF = 0.00477 (23/4824). AF 95% confidence interval is 0.00326. There are 0 homozygotes in GnomAd4. There are 36 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 79 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SMCHD1NM_015295.3 linkc.1957-3C>T splice_region_variant, intron_variant Intron 14 of 47 ENST00000320876.11 NP_056110.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SMCHD1ENST00000320876.11 linkc.1957-3C>T splice_region_variant, intron_variant Intron 14 of 47 5 NM_015295.3 ENSP00000326603.7 A6NHR9-1

Frequencies

GnomAD3 genomes
AF:
0.000520
AC:
79
AN:
152056
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00476
Gnomad FIN
AF:
0.0000946
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000676
Gnomad OTH
AF:
0.000958
GnomAD2 exomes
AF:
0.000795
AC:
140
AN:
176008
AF XY:
0.000932
show subpopulations
Gnomad AFR exome
AF:
0.000190
Gnomad AMR exome
AF:
0.000377
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000765
Gnomad FIN exome
AF:
0.000110
Gnomad NFE exome
AF:
0.000579
Gnomad OTH exome
AF:
0.000434
GnomAD4 exome
AF:
0.000732
AC:
1016
AN:
1388086
Hom.:
4
Cov.:
26
AF XY:
0.000824
AC XY:
565
AN XY:
685266
show subpopulations
African (AFR)
AF:
0.000286
AC:
9
AN:
31490
American (AMR)
AF:
0.000370
AC:
13
AN:
35172
Ashkenazi Jewish (ASJ)
AF:
0.0000408
AC:
1
AN:
24520
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37266
South Asian (SAS)
AF:
0.00424
AC:
316
AN:
74574
European-Finnish (FIN)
AF:
0.0000995
AC:
5
AN:
50244
Middle Eastern (MID)
AF:
0.00248
AC:
14
AN:
5638
European-Non Finnish (NFE)
AF:
0.000581
AC:
623
AN:
1071662
Other (OTH)
AF:
0.000608
AC:
35
AN:
57520
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
45
89
134
178
223
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000519
AC:
79
AN:
152174
Hom.:
0
Cov.:
32
AF XY:
0.000484
AC XY:
36
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41524
American (AMR)
AF:
0.000196
AC:
3
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.000576
AC:
2
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00477
AC:
23
AN:
4824
European-Finnish (FIN)
AF:
0.0000946
AC:
1
AN:
10572
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000677
AC:
46
AN:
67996
Other (OTH)
AF:
0.000948
AC:
2
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000413
Hom.:
0
Bravo
AF:
0.000340
Asia WGS
AF:
0.000289
AC:
3
AN:
3476

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Apr 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SMCHD1: BP4, BS1, BS2 -

Apr 18, 2017
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 17, 2023
Revvity Omics, Revvity
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Facioscapulohumeral muscular dystrophy 2 Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.51
CADD
Benign
10
DANN
Benign
0.41
PhyloP100
0.64
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00021
dbscSNV1_RF
Benign
0.14
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201069969; hg19: chr18-2706359; API